FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely cardiosurgery, and may accompany endarterectomy with using extracorporeal circulation. That is ensured by the intracoronary introduction of heparin dissolved in normal saline in proportions 1:1 in dose 50-100 mg in a deendothelised area during pharmacological asystole.
EFFECT: method provides improved effect of said surgery ensured by the higher concentration of heparin absorbed on a vascular wall.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OPEN ENDARTERECTOMY IN DIFFUSE ATHEROSCLEROTIC INVOLVEMENT OF ANTERIOR INTERVENTRICULAR ARTERY | 2018 |
|
RU2717372C2 |
| METHOD OF SURGICAL TREATMENT OF PATIENTS WITH COMBINED ATHEROSCLEROTIC AFFECTION OF CAROTID AND CORONARY ARTERIES | 2010 |
|
RU2476165C2 |
| METHOD OF ACUTE MYOCARDIAL INFARCTION TREATMENT | 2008 |
|
RU2365380C1 |
| METHOD FOR ASSESSMENT OF DIFFUSE ATHEROSCLEROTIC LESION OF CORONARY ARTERIES BEFORE REVASCULARIZATION OF MYOCARDIUM | 2018 |
|
RU2697986C1 |
| METHOD FOR INDUCTION OF EXTRACARDIAL MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2758024C1 |
| METHOD OF DETERMINING POSTOPERATIVE MANAGEMENT OF PATIENTS WITH CORONARY HEART DISEASE BASED ON THE SELECTED CLASSES OF ANGIOGRAPHIC RESULTS OF PERCUTANEOUS CORONARY INTERVENTION | 2022 |
|
RU2802854C1 |
| METHOD OF COMPLETE MINIMALLY INVASIVE ENDOSCOPICALLY ASSISTED MYOCARDIAL REVASCULARIZATION IN MULTIVASCULAR ATHEROSCLEROTIC CORONARY BED LESION | 2019 |
|
RU2723751C1 |
| APPLICATION OF LIQUID EMBOLIC SYSTEM TRUFILL n-BCA FOR PERFORATION TREATMENT OF DISTAL CORONARY ARTERY CONDITIONS OF HYPOCOAGULATION | 2015 |
|
RU2582534C1 |
| METHOD FOR IMMUNOLOGICAL PREDICTION OF SMALL MYOCARDIAL DAMAGE | 2014 |
|
RU2585391C1 |
| METHOD FOR OPTIMIZATION OF EARLY IMMUNOLOGICAL DIAGNOSTICS OF COMPLICATIONS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH IHD | 2017 |
|
RU2709458C2 |
